Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Healthcare Services Industry Analysis

UpdatedJun 05, 2026
DataAggregated Company Financials
Companies8
  • 7D-1.4%
  • 3M8.4%
  • 1Y-6.1%
  • YTD3.2%

Over the last 7 days, the Healthcare Services industry has dropped 1.4%, driven by pullbacks in Attendo and Ambea of 5.7% and 7.5%, respectively. Overall the industry is down 6.1% in 12 months. As for the next few years, earnings are expected to grow by 18% per annum.

Industry Valuation and Performance

Has the Swedish Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 05 Jun 2026SEK 93.7bSEK 91.7bSEK 3.3b18.3x28.3x1x
Sun, 03 May 2026SEK 91.3bSEK 90.5bSEK 3.1b18.8x29.6x1x
Tue, 31 Mar 2026SEK 83.7bSEK 90.3bSEK 3.1b18x27.2x0.9x
Thu, 26 Feb 2026SEK 84.8bSEK 89.9bSEK 3.1b17.9x27.8x0.9x
Sat, 24 Jan 2026SEK 90.0bSEK 88.6bSEK 2.9b19.4x31.2x1x
Mon, 22 Dec 2025SEK 61.3bSEK 72.8bSEK 2.4b17.7x25.8x0.8x
Wed, 19 Nov 2025SEK 61.7bSEK 73.1bSEK 2.4b16.8x25.9x0.8x
Fri, 17 Oct 2025SEK 63.6bSEK 72.3bSEK 2.0b17.1x32.6x0.9x
Sun, 14 Sep 2025SEK 66.4bSEK 72.1bSEK 2.0b18.1x34x0.9x
Tue, 12 Aug 2025SEK 65.9bSEK 72.1bSEK 1.9b16.9x34.6x0.9x
Thu, 10 Jul 2025SEK 62.9bSEK 71.3bSEK 1.7b16.7x36.9x0.9x
Sat, 07 Jun 2025SEK 58.9bSEK 71.0bSEK 1.7b15.8x34.7x0.8x
Mon, 05 May 2025SEK 60.6bSEK 70.3bSEK 1.6b18.6x37.6x0.9x
Wed, 02 Apr 2025SEK 84.9bSEK 84.1bSEK 1.8b20.5x48.2x1x
Fri, 28 Feb 2025SEK 55.2bSEK 69.8bSEK 1.4b19x39.3x0.8x
Sun, 26 Jan 2025SEK 51.7bSEK 68.5bSEK 1.4b17.2x37.7x0.8x
Tue, 24 Dec 2024SEK 49.5bSEK 68.5bSEK 1.4b17x36.1x0.7x
Thu, 21 Nov 2024SEK 45.7bSEK 68.8bSEK 1.4b16.9x33.3x0.7x
Sat, 19 Oct 2024SEK 48.3bSEK 66.7bSEK 1.2b18.9x38.8x0.7x
Mon, 16 Sep 2024SEK 49.1bSEK 66.5bSEK 1.2b18.9x39.6x0.7x
Wed, 14 Aug 2024SEK 45.5bSEK 66.7bSEK 1.2b14.4x37.9x0.7x
Fri, 12 Jul 2024SEK 47.8bSEK 64.9bSEK 1.3b14.1x36.7x0.7x
Sun, 09 Jun 2024SEK 47.1bSEK 64.9bSEK 1.3b14.6x36.2x0.7x
Tue, 07 May 2024SEK 43.7bSEK 65.4bSEK 1.3b12x33.3x0.7x
Thu, 04 Apr 2024SEK 36.6bSEK 63.9bSEK 1.2b12.8x29.8x0.6x
Sat, 02 Mar 2024SEK 36.2bSEK 63.3bSEK 1.2b12.2x29.6x0.6x
Mon, 29 Jan 2024SEK 39.9bSEK 62.0bSEK 941.0m13.2x42.4x0.6x
Wed, 27 Dec 2023SEK 36.7bSEK 61.5bSEK 938.4m13.6x39.1x0.6x
Fri, 24 Nov 2023SEK 35.7bSEK 62.2bSEK 949.5m12.5x37.6x0.6x
Sun, 22 Oct 2023SEK 29.6bSEK 60.6bSEK 904.2m10.7x32.7x0.5x
Tue, 19 Sep 2023SEK 32.3bSEK 61.0bSEK 905.6m9.3x35.6x0.5x
Thu, 17 Aug 2023SEK 34.7bSEK 60.7bSEK 945.2m8.3x36.7x0.6x
Sat, 15 Jul 2023SEK 35.5bSEK 58.5bSEK 766.4m8.9x46.3x0.6x
Mon, 12 Jun 2023SEK 36.9bSEK 58.6bSEK 768.6m10.1x48x0.6x
Price to Earnings Ratio

48x


Total Market Cap: SEK 36.9bTotal Earnings: SEK 768.6mTotal Revenue: SEK 58.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Healthcare Services Industry Price to Earnings3Y Average 34.8x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 28.3x which is lower than its 3-year average PE of 34.8x.
  • The 3-year average PS ratio of 0.75x is lower than the industry's current PS ratio of 1.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 63% per year over the last three years.
  • Revenues for these companies have grown 16% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market0.03%
Healthcare0.74%
Healthcare Services-1.41%
Healthcare Services1.90%
Healthcare Distributors0.77%
Healthcare Facilities-6.89%
Industry PE
  • Investors are most optimistic about the Healthcare Distributors industry, which is trading close to its 3-year average PE ratio of 53.1x.
    • Analysts are expecting annual earnings growth of 19.0%, which is higher than its past year's earnings decline of 3.7% per year.
  • Investors are most pessimistic about the Healthcare Facilities industry, which is trading close to its 3-year average of 15.2x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 24% over the next 5 years.
  • However this is lower than its past earnings growth rate of 69% per year.
  • In contrast, the Healthcare Facilities industry is expected to see its earnings grow by 11% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HEGR Hedera GroupSEK 0.6119.6%
+SEK 3.4m		-59.3%PS0.04x

Latest News

ATT
SEK 113.00
Attendo
7D
-4.2%
1Y
80.8%
AMBEA
SEK 141.60
Ambea
7D
-5.8%
1Y
26.3%
Narrative Update • Jun 04

AMBEA: Nordic Care Acquisitions And Dividend Will Drive Future Upside Potential

Analysts now see Ambea’s fair value at SEK 181.0 per share, with a slightly higher discount rate and a lower future P/E assumption. Together these factors explain the unchanged price target despite refined model inputs.
HUM
SEK 48.65
Humana
7D
-10.7%
1Y
31.0%
Narrative Update • Jun 03

HUM: Completed Share Buybacks Will Support Future Upside Potential

Analysts maintained their SEK 62.5 price target for Humana, keeping the fair value estimate unchanged. Slight adjustments to assumptions for the discount rate, revenue growth, profit margin and future P/E help provide context for the updated narrative rather than driving a headline valuation change.
MCOV B
SEK 208.50
Medicover
7D
-0.2%
1Y
-12.9%
Narrative Update • Jun 02

MCOV B: Lower Discount Rate Will Support Future Upside Potential

Analysts have nudged their Medicover price target slightly higher to around SEK257 per share, reflecting minor adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions in their models. What's in the News No recent company specific news items, periodical coverage or key developments were provided for Medicover in the supplied sources.
EQL
SEK 24.60
EQL Pharma
7D
-0.6%
1Y
-69.5%
Narrative Update • Jun 02

EQL: European Rollout And Supply Chain Improvements Will Drive Future Upside

Analysts have reduced their fair value estimate for EQL Pharma’s shares from SEK 75 to SEK 50, citing updates to their models that reflect revised assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News EQL Pharma issued earnings guidance for 2026/27, with sales growth below its long term 30% target and an EBITDA margin of 10%, reflecting impacts from supply shortages and one off effects.
HEGR
SEK 0.61
Hedera Group
7D
19.6%
1Y
-59.3%
ASKER
SEK 81.65
Asker Healthcare Group
7D
-1.6%
1Y
-23.4%
DEDI
SEK 43.30
Dedicare
7D
-3.1%
1Y
-0.7%